CLINICAL_TRIALS
trial_result
· 2016-01-11
Clinical Trial Update: Rituximab or Zevalin - Efficacy Trial of Therapeutic Alternatives (RoZetta) [Phase 3]
Summary
Phase 3 trial RoZetta comparing Rituximab versus Zevalin in follicular lymphoma was terminated with results posted in 2016.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Spectrum Pharmaceuticals, Inc | Conditions: Follicular Lymphoma | Phase 3 | Status: TERMINATED | Results posted: 2016-01-11